Note: See section 16, subsection 46(2), section 49, subsection 54(3) and sections 55 and 61.
ABAMECTIN:
(a) in preparations for pesticidal use containing 4% or less of abamectin except when included in Schedule 5; or
(b) in slow‑release plastic matrix ear tags for livestock use containing 1 g or less of abamectin.
ACEPHATE.
ACETAMIPRID except in preparations containing 1% or less of acetamiprid.
ACETIC ACID (excluding its salts and derivatives) and preparations containing more than 80% of acetic acid (CH3COOH) except when included in Schedule 2.
ACETIC ANHYDRIDE excluding its derivatives.
ACIFLUORFEN.
ACINITRAZOLE except in preparations containing 20% or less of acinitrazole.
ACLONIFEN.
ALBENDAZOLE for the treatment of animals except:
(b) in intraruminal implants each containing 3.85 g or less of albendazole.
ALDRIN.
ALKALINE SALTS, being the carbonate, silicate or phosphate salts of sodium or potassium alone or in any combination for non‑domestic use:
(a) in solid automatic dishwashing preparations, the pH of which in a 500 g/L aqueous solution or mixture is more than 12.5; or
(b) in liquid or semi‑solid automatic dishwashing preparations, the pH of which is more than 12.5.
ALKOXYLATED FATTY ALKYLAMINE POLYMER except:
(b) in preparations containing 20% or less of alkoxylated fatty alkylamine polymer.
ALLETHRIN except:
(b) in insecticidal mats containing 20% or less of allethrin; or
(c) in other preparations containing 1% or less of allethrin.
ALLYL ESTERS (excluding derivatives) being:
(a) ALLYL CYCLOHEXANEACETATE (CAS No. 4728‑82‑9); or
(b) ALLYL CYCLOHEXANEPROPIONATE (CAS No. 2705‑87‑5); or
(c) ALLYL HEPTANOATE/ALLYL HEPTYLATE (CAS No. 142‑19‑8); or
in preparations containing 0.1% or less of free allyl alcohol by weight of allyl ester except in preparations containing 5% or less of allyl esters with 0.1% or less of free allyl alcohol by weight of allyl esters.
ALPHA‑CYPERMETHRIN:
(a) in aqueous preparations containing 30% or less of alpha‑cypermethrin; or
(b) in other preparations containing 10% or less of alpha‑cypermethrin;
AMICARBAZONE.
AMIDITHION.
AMIDOPROPYL BETAINES except:
(a) in cosmetic wash‑off preparations containing 30% or less of amidopropyl betaines and, if containing more than 5% of amidopropyl betaines when labelled with a warning to the following effect:
IF IN EYES WASH OUT IMMEDIATELY WITH WATER;
in cosmetic leave‑on preparations containing 1.5% or less of amidopropyl betaines; or
(b) in other preparations containing 30% or less of amidopropyl betaines and, if containing more than 5% of amidopropyl betaines, when labelled with warnings to the following effect:
2‑AMINO‑6‑CHLORO‑4‑NITROPHENOL in hair dye and eyebrow/eyelash colouring preparations, except:
(a) in preparations containing 2% or less of 2‑amino‑6‑chloro‑4‑nitrophenol when applied directly to the hair, or containing 2% or less of 2‑amino‑6‑chloro‑4‑nitrophenol after mixing and when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;
(b) in eyelash and eyebrow tinting products containing 1.5% or less of 2‑amino‑6‑chloro‑4‑nitrophenol after mixing for use when the immediate container and primary pack are labelled with the following statement:
WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals, and when used for eyelash or eyebrow tinting may cause injury to the eye. A preliminary test according to the accompanying directions should be made before use;
4‑AMINO‑m‑CRESOL in hair dyes and eyebrow/eyelash colouring preparations except:
(a) in hair dye preparations containing 1.5% or less of 4‑amino‑m‑cresol after mixing for use when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;
written in letters not less than 1.5mm in height; or
(b) in eyelash and eyebrow tinting products containing 1.5% or less of 4‑amino‑m‑cresol after mixing for use when the immediate container and primary pack are labelled with the following statement:
WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals, and when used for eyelash or eyebrow tinting may cause injury to the eye. A preliminary test according to the accompanying directions should be made before use;
2‑AMINO‑5‑ETHYLPHENOL in hair dye preparations except in preparations containing 1% or less of 2‑amino‑5‑ethylphenol when the immediate container and primary pack are labelled with the following statements:
(b) WARNING – This product contains ingredients which may cause skin irritation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes and eyebrows; to do so may be injurious to the eye;
4‑AMINO‑2‑HYDROXYTOLUENE in hair dyes and eyebrow/eyelash colouring products except:
(a) in hair dye preparations containing 1.5% or less of 4‑amino‑2‑hydroxytoluene after mixing for use when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;
written in letters not less than 1.5mm in height; or
(b) in eyelash and eyebrow tinting products containing 1.5% or less of 4‑amino‑2‑hydroxytoluene after mixing for use when the immediate container and primary pack are labelled with the following statement:
WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals, and when used for eyelash or eyebrow tinting may cause injury to the eye. A preliminary test according to the accompanying directions should be made before use;
AMINOCARB in preparations containing 25% or less of aminocarb.
AMINOETHOXYVINYLGLYCINE except in preparations containing 15% or less of aminoethoxyvinylglycine.
1‑AMINOMETHANAMIDE DIHYDROGEN TETRAOXOSULFATE.
4‑AMINO‑3‑NITROPHENOL except:
(a) in non‑oxidative hair dye preparations and eyebrow/eyelash colouring products containing 1% or less of 4‑amino‑3‑nitrophenol when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use;
(b) in oxidative hair dye preparations and eyebrow/eyelash colouring products containing 1% or less of 4‑amino‑3‑nitrophenol after mixing under oxidative conditions when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use;
2,2'‑[(4‑AMINO‑3‑NITROPHENYL)IMINO]BISETHANOL (including its salts) except:
(a) in non‑oxidative hair dye preparations containing 2.5% or less of 2,2'‑[(4‑amino‑3‑nitrophenyl)imino]bisethanol after mixing when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use;
(b) in oxidative hair dye preparations containing 1.25% or less of 2,2'‑[(4‑amino‑3‑nitrophenyl)imino]bisethanol after mixing under oxidative conditions when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;
m‑AMINOPHENOL except when used in hair dye and eyebrow/eyelash preparations at a concentration of 1.2% or less of m‑aminophenol after mixing for use when the immediate container and primary pack are labelled with the following statements:
(b) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use;
p‑ AMINOPHENOL except when used in hair dye and eyebrow/eyelash colouring products at a concentration of 1% or less of p‑aminophenol after mixing for use when the immediate container and primary pack are labelled with the following statements:
(b) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use;
AMINOPYRALID except when included in Schedule 5.
AMITRAZ.
AMMONIA (excluding its salts and derivatives other than ammonium hydroxide) except:
(b) in preparations for human internal therapeutic use; or
(c) in preparations for inhalation when absorbed in an inert solid material; or
(d) in preparations containing 0.5% or less of ammonia.
AMMONIUM COCOYL ISETHIONATE, except in cosmetic rinse‑off preparations containing 30% or less of ammonium cocoyl isethionate and, if containing more than 5% of ammonium cocoyl isethionate, when labelled with a warning to the following effect:
AMMONIUM PERSULFATE in hair preparations.
ANILINE (excluding its salts and derivatives) except in preparations containing 1% or less of aniline.
ANTIMONY COMPOUNDS except:
(b) antimony chloride in polishes; or
(c) antimony titanate pigments in paint; or
(d) in paints or tinters containing 5% or less of antimony calculated on the non‑volatile content of the paint or tinter.
ARBUTIN (ALPHA) except:
(a) in preparations for application to the face containing 2% or less alpha‑arbutin with hydroquinone levels of 10mg/kg or less; or
(b) in preparations for application to the body containing 0.5% or less alpha‑arbutin with hydroquinone levels of 10mg/kg or less.
ARBUTIN (BETA) except:
(b) oral herbal preparations containing 500 mg or less beta‑arbutin per recommended daily dose; or
(c) in preparations for application to the face containing 7% or less beta‑arbutin with hydroquinone levels of 10mg/kg or less.
ARBUTIN (DEOXY OR OTHER DERIVATIVES).
ARSENIC:
(a) in ant poisons containing 0.4% or less of arsenic; or
(b) in animal feed premixes containing 4% or less of arsenic; or
(c) in preparations for the treatment of animals except thiacetarsamide when included in Schedule 4,
except when separately specified in this Schedule.
ASPIRIN for the treatment of animals except when included in Schedule 4 or 5.
AZACONAZOLE except in preparations containing 1% or less of azaconazole.
AZADIRACHTA INDICA (Neem) including its extracts and derivatives except:
(b) in preparations for human internal use; or
(c) debitterised neem seed oil; or
(d) in preparations for human dermal therapeutic use containing cold pressed neem seed oil, when in a container fitted with a child‑resistant closure and compliant with the requirements of the required advisory statements for medicine labels; or
(e) in preparations for dermal use containing 1% or less of cold pressed neem seed oil.
AZAMETHIPHOS.
AZOBENZENE.
BAMBERMYCIN (flavophospholipol) in animal feed premixes for growth promotion containing 2% or less of antibiotic substances.
BARIUM SALTS except:
(b) barium sulfate; or
(c) in paints or tinters containing 5% or less of barium calculated on the non‑volatile content of the paint or tinter.
BASIC BLUE 26 (CAS No. 2580‑56‑5) except when used as a colourant in cosmetics not intended to be in contact with mucous membranes.
(a) in preparations for skin colouration and dyeing of eyelashes or eyebrows; or
(b) in hair dye preparations containing 1% or less of Basic Orange 31 when the immediate container and primary pack are labelled with the following statements:
(i) KEEP OUT OF REACH OF CHILDREN;
(ii) IF IN EYES WASH OUT IMMEDIATELY WITH WATER; and
(iii) WARNING – This product contains ingredients which may cause skin irritation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;
BASIC RED 76 (CAS No. 68391‑30‑0) in non‑oxidative hair dye preparations and eyebrow/eyelash colouring products containing 2% or less of Basic Red 76 and 0.001% or less of free o‑anisidine.
BAY OIL except:
(a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the required advisory statements for medicine labels; or
(b) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and compliant with the requirements of the required advisory statements for medicine labels; or
(c) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:
(d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and labelled with the warnings:
(e) in preparations containing 25% or less of bay oil.
BEAUVERIA BASSIANA except when included in Schedule 5.
BENDIOCARB:
(a) in wettable powders containing 80% or less of bendiocarb when packed in containers or primary packs containing not less than 100 g of bendiocarb; or
(b) in wettable powders containing 20% or less of bendiocarb and not less than 0.002% of denatonium benzoate when packed in containers or primary packs containing not less than 48 g of bendiocarb and labelled for use as a fly control preparation; or
(c) in insoluble granular preparations containing 5% or less of bendiocarb; or
(d) when impregnated in plastic resin strip material containing 10% or less of bendiocarb;
BENQUINOX.
BENSULIDE.
BENZALKONIUM CHLORIDE except:
(b) in preparations containing 5% or less of benzalkonium chloride.
1,2‑BENZENEDIOL.
BENZOVINDIFLUPYR.
6‑BENZYLADENINE except in preparations containing 10% or less of 6‑benzyladenine.
BERYLLIUM.
BETACYFLUTHRIN in preparations containing 12.5% or less of betacyfluthrin except when included in Schedule 5.
BETA‑CYPERMETHRIN.
BHC (excluding lindane).
BICYCLOPYRONE except when included in Schedule 5.
BIFENTHRIN in preparations containing 25% or less of bifenthrin except in preparations containing 0.5% or less of bifenthrin.
BIFLUORIDES (including ammonium, potassium and sodium salts) in preparations containing 3% or less of total bifluorides except when included in Schedule 5.
BIOALLETHRIN except:
(b) in preparations containing 1% or less of bioallethrin.
1,3‑BIS(2,4‑DIAMINOPHENOXY)PROPANE (including its salts) except when in hair dye preparations containing 1.2% or less of 1,3‑bis(2,4‑diaminophenoxy)propane after mixing when the immediate container and primary pack are labelled with the following statements:
(b) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;
BIS‑ISOBUTYL PEG/PPG‑20/35/AMODIMETICONE COPOLYMER except in rinse‑off cosmetic products containing 1% or less of bis‑isobutyl PEG/PPG‑20/35/amodimeticone copolymer when labelled with a warning to the following effect:
IF IN EYES, WASH OUT IMMEDIATELY WITH WATER.
N,N‑BIS(PHENYLMETHYLENE)‑BICYCLO‑(2.2.1)HEPTANE‑2,5‑DIMETHANAMINE except in preparations containing 1% or less of N,N‑bis(phenylmethylene)‑bicyclo‑ (2.2.1)heptane‑2,5‑dimethanamine, or a combination of N,N‑bis(phenylmethylene)‑bicyclo‑(2.2.1)heptane‑2,5‑dimethanamine and N,N‑bis(phenylmethylene)‑bicyclo‑(2.2.1)heptane‑2,6‑dimethanamine, when labelled with statements to the effect of:
(a) IRRITANT; and
(b) REPEATED EXPOSURE MAY CAUSE SENSITISATION; and
(c) Avoid contact with eyes; and
(d) Avoid contact with skin; and
(e) Wear protective gloves when mixing or using; and
(f) Ensure adequate ventilation when using.
N,N‑BIS(PHENYLMETHYLENE)‑BICYCLO‑(2.2.1)HEPTANE‑2,6‑DIMETHANAMINE except in preparations containing 1% or less of N,N‑bis(phenylmethylene)‑bicyclo‑(2.2.1)heptane‑2,6‑dimethanamine, or a combination of N,N‑bis(phenylmethylene)‑bicyclo‑(2.2.1)heptane‑2,5‑dimethanamine and N,N‑bis(phenylmethylene)‑bicyclo‑(2.2.1)heptane‑2,6‑dimethanamine, when labelled with statements to the effect of:
(a) IRRITANT; and
(b) REPEATED EXPOSURE MAY CAUSE SENSITISATION; and
(c) Avoid contact with eyes; and
(d) Avoid contact with skin; and
(e) Wear protective gloves when mixing or using; and
(f) Ensure adequate ventilation when using.
BITHIONOL for the treatment of animals.
BORON TRIFLUORIDE in preparations containing 1% or less of boron trifluoride (BF3) except when included in Schedule 5.
BRODIFACOUM in preparations containing 0.25% or less of brodifacoum.
BROFLANILIDE except when included in Schedule 5.
BROMADIOLONE in preparations containing 0.25% or less of bromadiolone.
BROMETHALIN in rodent baits containing 0.01% or less of bromethalin.
BROMOFORM except when included in Schedule 4.
BROMOPHOS.
BROMOPHOS‑ETHYL.
BROMOXYNIL.
BROMUCONAZOLE except when included in Schedule 5.
BROTIANIDE.
BUNAMIDINE.
BUTACARB.
BUTOXYCARBOXIM except when included in Schedule 5.
2‑BUTOXYETHANOL and its acetates except:
(a) in plant growth regulator preparations containing 20% or less of such substances; or
(b) in other preparations containing 10% or less of such substances.
2‑BUTOXY‑2'‑THIOCYANODIETHYL ETHER.
n‑BUTYL ALCOHOL except:
(b) in preparations containing 5% or less of n‑butyl alcohol; or
(c) in preparations for cosmetic or therapeutic use other than in spray form.
BUTYRIC ACID in preparations for use as insect lures.
CACODYLIC ACID:
(a) in animal feed premixes containing 4% or less of arsenic; or
(b) in herbicide or defoliant preparations containing 10% or less of cacodylic acid.
CADMIUM COMPOUNDS except:
(b) in paints or tinters containing 0.1% or less of cadmium calculated on the non‑volatile content of the paint or tinter.
CADUSAFOS in aqueous preparations containing 20% or less of microencapsulated cadusafos.
CAFFEINE except:
(b) in divided preparations for internal human therapeutic use when labelled with a maximum recommended daily dose of no greater than 600 mg of total caffeine; or
(c) in undivided preparations for internal human therapeutic use with a concentration of less than 5% of total caffeine and when labelled with a maximum recommended daily dose of no greater than 600 mg of total caffeine; or
(d) in preparations for external use; or
(e) in other preparations with a concentration of less than 5% of caffeine.
CAJUPUT OIL except:
(a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the required advisory statements for medicine labels; or
(b) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and compliant with the requirements of the required advisory statements for medicine labels; or
(c) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:
(d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and labelled with the warnings:
(e) in preparations containing 25% or less of cajuput oil; or
(f) in oils containing 25% or less of cajuput oil.
CALCIFEROL in rodent baits containing 0.1% or less of calciferol.
CAMBENDAZOLE.
CAMPHOR except:
(b) when enclosed in an inhaler device which prevents ingestion of its contents; or
(c) in solid or semi‑solid preparations containing 12.5% or less of camphor; or
(d) in liquid preparations containing 2.5% or less of camphor; or
(e) in essential oils when the camphor is present as a natural component of the oil:
(i) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the required advisory statements for medicine labels; or
(ii) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and compliant with the requirements of the required advisory statements for medicine labels; or
(iii) in essential oils other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:
(A) KEEP OUT OF REACH OF CHILDREN; and
(B) NOT TO BE TAKEN; or
(iv) in essential oils other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and labelled with the warnings:
(A) KEEP OUT OF REACH OF CHILDREN; and
(B) NOT TO BE TAKEN; or
(f) in rosemary oil, sage oil (Spanish), or lavandin oil as such.
CAPTAN.
CARBARYL except when included in Schedule 4 or 5.
CARBON DISULFIDE.
CARBAMIDE PEROXIDE except:
(b) in other preparations containing 9% or less of carbamide peroxide.
CARBETAMIDE.
CASTOR OIL, MONOMALEATE (excluding its salts and derivatives) in preparations for cosmetic use except in wash‑off preparations containing 1% or less of castor oil, monomaleate.
CHLORALOSE (alpha‑CHLORALOSE) when packed and labelled for use as a pesticide.
CHLORDANE.
CHLORFENAPYR in preparations containing 36% or less of chlorfenapyr except when included in Schedule 5.
CHLORFENETHOL.
CHLORHEXIDINE in preparations containing 7% or less of chlorhexidine except:
(b) in preparations containing 1% or less of chlorhexidine; or
(c) when in solid preparations.
CHLORINATING COMPOUNDS except:
(b) when separately specified in these Schedules; or
(c) sodium hypochlorite preparations with a pH of less than 11.5; or
(d) in liquid preparations containing not less than 2% but not more than 4% of available chlorine when labelled with the statements:
WARNING – Ensure adequate ventilation when using. Vapour may be harmful. May give off dangerous gas if mixed with other products; or
(e) in liquid preparations containing less than 2% of available chlorine; or
(f) in other preparations containing 4% or less of available chlorine.
CHLORMEQUAT.
CHLOROACETAMIDE
(a) in preparations for cosmetic use; or
(b) in preparations for topical therapeutic use; or
(c) in other preparations containing more than 0.3% of chloroacetamide.
2‑CHLORO‑6‑(ETHYLAMINO)‑4‑NITROPHENOL except:
(a) in non‑oxidative hair dye preparations containing 3% or less of 2‑chloro‑6‑(ethylamino)‑4‑nitrophenol after mixing for use when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use;
(b) in oxidative hair dye preparations containing 1.5% or less of 2‑chloro‑6‑(ethylamino)‑4‑nitrophenol after mixing for use when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use;
CHLOROFORM except:
(b) in preparations containing 10% or less of chloroform.
ALPHA‑CHLOROHYDRIN.
CHLOROPHACINONE.
(E)‑(S)‑1‑(4‑CHLOROPHENYL)‑4,4‑DIMETHYL‑2‑(1H‑1,2,4‑TRIAZOL‑1‑YL)PENT‑1‑EN‑3‑OL (uniconazole‑p) except in preparations containing 5% or less of (E)‑(S)‑1‑(4‑chlorophenyl)‑4,4‑dimethyl‑2‑(1H‑1,2,4‑triazol‑1‑yl)pent‑1‑en‑3‑ol.
CHLOROPICRIN in preparations containing 5% or less of chloropicrin.
CHLOROTHALONIL except in water‑based paint containing 0.5% or less of chlorothalonil.
2‑CHLORO‑6‑(TRICHLOROMETHYL)‑PYRIDINE.
CHLORPYRIFOS except:
(b) in prepared potting or soil mixes containing 100 g or less of chlorpyrifos per cubic metre.
CHLORPYRIFOS‑METHYL.
CHLORTHIAMID.
CHROMATES (including dichromates) except in paints or tinters containing 5% or less of chromium as the ammonium, barium, calcium, iron, potassium, sodium, strontium or zinc chromate calculated on the non‑volatile content of the paint or tinter.
CHROMIUM TRICHLORIDE HEXAHYDRATE except in preparations containing 0.5% or less chromium.
CHROMIUM TRIOXIDE (excluding its salts and derivatives).
CHRYSOIDINE BASE except when in Schedule 10.
CINEOLE except:
(a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the required advisory statements for medicine labels; or
(b) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and compliant with the requirements of the required advisory statements for medicine labels; or
(c) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:
(d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and labelled with the warnings:
(e) in preparations containing 25% or less of cineole; or
(f) in oils containing 25% or less of cineole; or
(g) in rosemary oil or camphor oil (white).
CINNAMON LEAF OIL except:
(a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the required advisory statements for medicine labels; or
(b) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and compliant with the requirements of the required advisory statements for medicine labels; or
(c) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:
(d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and labelled with the warnings:
(e) in preparations containing 25% or less of cinnamon leaf oil.
CLIMBAZOLE except:
(b) in leave‑on hair, face and foot cosmetic preparations containing 0.5% or less of climbazole; or
(c) in other preparations (that are not leave‑on cosmetic preparations) containing 2% or less of climbazole.
CLODINAFOP‑PROPARGYL.
CLOMAZONE.
CLOSANTEL.
CLOTHIANIDIN except
(b) when in gel preparations dispensed in sealed cartridges containing 1% or less of clothianidin.
CLOTRIMAZOLE for the external treatment of animals.
CLOVE OIL except:
(b) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the required advisory statements for medicine labels; or
(c) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and compliant with the requirements of the required advisory statements for medicine labels; or
(d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:
(ii) NOT TO BE TAKEN;
(e) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and labelled with the warnings:
(f) in preparations containing 25% or less of clove oil.
N‑COCO‑1,3‑DIAMINOPROPANE.
COCOYL GLYCINATE in cosmetic preparations except:
(a) in leave‑on preparations containing 5% or less of cocoyl glycinate; or
(b) in wash‑off preparations containing 30% or less of cocoyl glycinate and, when containing more than 5% of cocoyl glycinate labelled with a warning to the following effect:
COPPER ACETATE except:
(b) in preparations containing 5% or less of copper acetate.
COPPER COMPOUNDS except:
(b) in preparations for human internal use containing 5 mg or less of copper per recommended daily dose; or
(c) pigments where the solubility of the copper compound(s) in water is 1 g per litre or less; or
(d) in feed additives containing 1% or less of copper; or
(e) in other preparations containing 5% or less of copper compounds.
COPPER HYDROXIDE except:
(b) in preparations containing 12.5% or less of copper hydroxide.
COPPER NITRATE in preparations containing copper chloride for the treatment of footrot in sheep.
COPPER OXIDES except:
(c) in marine paints; or
(d) in other preparations containing 5% or less of copper oxides.
COPPER OXYCHLORIDE except:
(b) in preparations containing 12.5% of less of copper oxychloride.
COPPER SULFATE except:
(c) in other preparations containing 5% or less of copper sulfate.
COUMAPHOS:
(a) in slow‑release plastic matrix ear tags for livestock use containing 6 g or less of coumaphos; or
(b) in other preparations containing 5% or less of coumaphos.
COUMATETRALYL in rodenticides containing 1% or less of coumatetralyl except when included in Schedule 5.
CREOSOTE derived from wood other than beechwood except:
(b) in preparations for human therapeutic use containing 10% or less of creosote derived from wood other than beechwood; or
(c) in other preparations containing 3% or less of phenols and homologues of phenol boiling below 220°C.
CROTOXYPHOS.
CRUFOMATE.
CYANAMIDE.
CYANAZINE.
CYCLANILIDE.
N‑CYCLOHEXYLDIAZENIUMDIOXY‑POTASSIUM.
CYCLOSILAZANES, DI‑ME, ME HYDROGEN, POLYMERS WITH DI‑ME, ME HYDROGEN SILAZANES, REACTION PRODUCTS WITH 3‑(TRIETHOXYSILYL)‑1‑PROPANAMINE (CAS 475645‑84‑2) when presented in a wipe and when packaged in a container with a child‑resistant closure, with chemical resistant gloves and labelled with the following effect:
(a) DO NOT USE WITHOUT PROTECTIVE GLOVES; and
(b) KEEP OUT OF EYES.
CYFLUTHRIN except:
(b) in pressurised spray packs containing 1% or less of cyfluthrin.
CYOMETRINIL.
CYPERMETHRIN except when included in Schedule 5.
CYPHENOTHRIN except when included in Schedule 5.
CYTHIOATE except when included in Schedule 5.
2,4‑D except when included in Schedule 5.
DAZOMET.
DELTAMETHRIN:
(a) in aqueous preparations containing 25% or less of deltamethrin, when no organic solvent, other than 10% or less of a glycol, is present; or
(b) in wettable granular preparations containing 25% or less of deltamethrin; or
(c) in water‑dispersible tablets each containing 500 mg or less of deltamethrin; or
(d) in emulsifiable concentrates containing 11% or less of deltamethrin in a solvent containing 40% or less of acetophenone and 45% or less of liquid hydrocarbons; or
(e) in other preparations containing 3% or less of deltamethrin;
(f) when included in Schedule 5; or
(g) in factory prepared mosquito nets containing 1% or less of deltamethrin; or
(h) in preparations containing 0.1% or less of deltamethrin.
(a) in cosmetic rinse‑off preparations containing 8% or less of 1‑deoxy‑1‑(methylamino)‑d‑glucitol N‑coco acyl derivatives when labelled with the following statement:
IF IN EYES WASH OUT IMMEDIATELY WITH WATER, or
(b) in household cleaning preparations, other than those intended to be sprayed, containing 10% or less of 1‑deoxy‑1‑(methylamino)‑d‑glucitol N‑coco acyl derivatives when labelled with the following statement:
2,4‑DIAMINOPHENOXYETHANOL except when used in hair dye and eyebrow/eyelash preparations at concentrations of 2% or less of 2,4‑diaminophenoxyethanol after mixing for use when the immediate container and primary pack are labelled with the following statements:
(b) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use;
DIAZINON except when included in Schedule 5.
DICAMBA (including its salts and derivatives) except when included in Schedule 5.
DICHLOBENIL.
DICHLOFENTHION.
DICHLOFLUANID.
o‑DICHLOROBENZENE.
DICHLOROETHYL ETHER.
DICHLOROISOCYANURIC ACID except:
(b) in liquid preparations containing not less than 2% but not more than 4% of available chlorine when labelled with the statements:
WARNING – Ensure adequate ventilation when using. Vapour may be harmful. May give off dangerous gas if mixed with other products; or
(c) in liquid preparations containing less than 2% of available chlorine; or
(d) in other preparations containing 4% or less of available chlorine.
4,5‑DICHLORO‑2‑N‑OCTYL‑3(2H)‑ISOTHIAZOLONE.
DICHLOROPHEN except:
(b) in fabrics other than when:
(i) for human therapeutic use; or
(ii) as part of a registered pesticidal product.
1,2‑DICHLOROPROPANE.
2,4‑DICHLORPROP (including the R and S enantiomers).
DICHLORVOS in preparations containing 50% or less of dichlorvos except when included in Schedule 5.
DICLOFOP‑METHYL.
DICYCLANIL except in preparations containing 6.5% or less of dicyclanil.
DIDECYLDIMETHYLAMMONIUM SALTS except in preparations containing 1% or less of didecyldimethylammonium salts labelled with the statement:
Avoid contact with eyes.
DIELDRIN.
DIETHANOLAMINE (excluding its salts and derivatives) except:
(b) in preparations containing 5% or less of diethanolamine.
DIETHYLENE GLYCOL (excluding its salts and derivatives) except:
(b) in paints or paint tinters; or
(c) in toothpastes or mouthwashes containing more than 0.25% of diethylene glycol; or
(d) in other preparations containing 2.5% or less of diethylene glycol.
DIETHYLENE GLYCOL MONOMETHYL ETHER.
DIFENACOUM in preparations containing 0.25% or less of difenacoum.
DIFENZOQUAT.
DIFETHIALONE in rodent baits containing 0.0025% or less of difethialone.
5,6‑DIHYDROXYINDOLINE.
DIMETHENAMID‑P.
DIMETHIPIN.
DIMETHOATE.
2,6‑DIMETHOXY‑3,5‑PYRIDINEDIAMINE except when used in hair dye and eyebrow/eyelash colouring products at a concentration of 0.25% or less of 2,6‑dimethoxy‑3,5‑pyridinediamine after mixing for use when the immediate container and primary pack are labelled with the following statements:
(b) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use;
DIMETHYLACETAMIDE except when included in Schedule 5.
N,N‑DIMETHYLDECANAMIDE.
DIMETHYLFORMAMIDE except:
(b) in silicone rubber mastic containing 2% or less of dimethylformamide.
4,4‑DIMETHYL‑1‑CYCLOHEXENE‑1‑PROPANAL except:
(a) in leave‑on cosmetic preparations containing 0.1% or less of 4,4‑dimethyl‑1‑cyclohexene‑1‑propanal; or
(b) in rinse‑off cosmetic preparations containing 0.5% or less of 4,4‑dimethyl‑1‑cyclohexene‑1‑propanal; or
(c) in other preparations containing 1% or less of 4,4‑dimethyl‑1‑cyclohexene‑1‑propanal.
3,7‑DIMETHYL‑2,6‑OCTADIEN‑1‑OL and its isomers except in products containing 5% or less 3,7‑dimethyl‑2,6‑octadien‑1‑ol and its isomers.
N,N‑DIMETHYLOCTANAMIDE.
DIMETHYL SULFOXIDE (excluding dimethyl sulfone):
(a) when not for therapeutic use; or
(b) in cosmetic preparations; or
(c) for the treatment of animals:
(i) when combined with no other therapeutic substance(s); or
(ii) in liquid preparations containing copper salicylate and 1% or less of methyl salicylate as the only other therapeutic substances; or
(iii) in clay poultices containing 2% or less of dimethyl sulfoxide; or
(d) in other preparations except when containing 10% or less of dimethyl sulfoxide.
DIMPROPYRIDAZ except when included in Schedule 5.
DINITROCRESOLS and their homologues in preparations containing 5% or less of such compounds except:
DINITROPHENOLS and their homologues in preparations containing 5% or less of such compounds except:
DIOXACARB.
DIOXANE.
DIPHACINONE.
DIQUAT in preparations containing 20% or less of diquat.
DIRECT RED 254 except when included in Schedule 5.
DISPERSE YELLOW 3 except when in Schedule 10.
DISULFIRAM except when included in Schedule 4.
DISULFOTON in granular preparations containing 5% or less of disulfoton.
DITHIANON.
DITHIAZANINE in preparations containing 2% or less of dithiazanine for the treatment of animals.
DIUREDOSAN.
N‑(N‑DODECYL)‑2‑PYRROLIDONE except:
DODINE.
DORAMECTIN for external use for the treatment of animals, in preparations containing 2% or less of doramectin.
DSMA in herbicide or defoliant preparations containing 10% or less of DSMA.
ECONAZOLE for the external treatment of animals.
EMAMECTIN in preparations containing 5% or less of emamectin except when included in Schedule 5.
EMODEPSIDE for the treatment of animals except when included in Schedule 5.
ENDOSULFAN in aqueous preparations containing 33% or less of microencapsulated endosulfan.
ENDOTHAL in preparations containing 20% or less of endothal.
EPRINOMECTIN for internal use in preparations containing 5% or less of eprinomectin except when included in Schedule 5.
EPTC.
ESBIOTHRIN except:
(b) in pressurised spray packs containing 1% or less of esbiothrin.
ESFENVALERATE except when included in Schedule 5.
ETHEPHON (excluding its salts and derivatives).
ETHER except:
(a) when included in Schedule 2, 4 or 5; or
(b) in preparations containing 10% or less of ether.
ETHIOFENCARB.
ETHOATE‑METHYL.
ETHOPROPHOS in granular formulations containing 10% or less of ethoprophos and 2% of linseed oil.
ETHYL BROMIDE.
ETHYLENE CHLOROHYDRIN.
ETHYLENE DICHLORIDE.
ETHYLENE GLYCOL (excluding its salts and derivatives) except:
(b) in paints or paint tinters; or
(c) in toothpastes or mouthwashes containing more than 0.25% of ethylene glycol; or
(d) in other preparations containing 2.5% or less of ethylene glycol.
ETHYLENE GLYCOL MONOALKYL ETHERS and their acetates, except:
(b) in preparations containing 10% or less of such substances.
ETHYL FORMATE when packed and labelled for use as a fumigant.
ETHYLHEXANEDIOL except in preparations containing 5% or less of ethylhexanediol.
2‑ETHYLHEXANOIC ACID and its alkyl esters except in preparations containing 5% or less calculated as 2‑ethylhexanoic acid.
ETRIMFOS.
EUCALYPTUS OIL except:
(a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the required advisory statements for medicine labels; or
(b) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and compliant with the requirements of the required advisory statements for medicine labels; or
(c) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:
(d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and labelled with the warnings:
(e) in preparations containing 25% or less of eucalyptus oil.
EUGENOL except:
(b) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the required advisory statements for medicine labels; or
(c) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and compliant with the requirements of the required advisory statements for medicine labels; or
(d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:
(e) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and labelled with the warnings:
(f) in preparations containing 25% or less of eugenol.
FAMOXADONE.
FAMPHUR in preparations containing 20% or less of famphur.
FEBANTEL except:
(a) in divided preparations containing 1000 mg or less of febantel per dosage unit; or
(b) in undivided preparations containing 10% or less of febantel.
FENAMIPHOS in granular preparations containing 5% or less of fenamiphos.
FENAZAFLOR.
FENBUTATIN OXIDE.
FENCHLORPHOS.
FENITROTHION.
FENOXACRIM in preparations for the treatment of carpets during manufacture.
FENPROPIDIN.
FENPYROXIMATE.
FENTHION in preparations containing 60% or less of fenthion except when included in Schedule 5.
FENVALERATE.
FIPRONIL except:
(b) in preparations containing 0.05% or less of fipronil.
FLOCOUMAFEN in preparations containing 0.005% or less of flocoumafen.
FLONICAMID.
FLUAZAINDOLIZINE except when included in Schedule 5.
FLUAZIFOP‑BUTYL.
FLUAZIFOP‑p‑BUTYL.
FLUAZINAM.
FLUCOFURON in preparations for the treatment of carpets during manufacture.
FLUENSULFONE.
FLUMETHRIN except when included in Schedule 5.
FLUMIOXAZIN when contained in water soluble bags individually packed in sealed sachets.
FLUORIDES except:
(b) in preparations for human use; or
(c) in preparations containing 15 mg/kg or less of fluoride ion.
FLUPROPANATE.
FLUPYRADIFURONE.
FLUQUINCONAZOLE.
FLUSILAZOL.
FLUTRIAFOL except in fertilisers containing 0.5% or less of flutriafol.
FLUVALINATE except when included in Schedule 5.
FOMESAFEN SODIUM.
FORMALDEHYDE (excluding its derivatives) in preparations containing 0.05% or more of free formaldehyde except:
(b) in oral hygiene preparations; or
(d) in nail hardener cosmetic preparations containing 0.2% or less of free formaldehyde when labelled with the statement:
PROTECT CUTICLES WITH GREASE OR OIL;
(e) in all other cosmetic preparations; or
(f) in other preparations containing 0.2% or less of free formaldehyde when labelled with the warning statement:
FORMOTHION.
FOSPIRATE except when included in Schedule 5.
FUMAGILLIN.
FURFURAL except in preparations containing 0.1% or less of furfural.
GLUTARAL except:
(b) in preparations containing 0.5% or less of glutaral when labelled with the statements:
IRRITANT; and
Avoid contact with eyes.
GLYCERYL THIOGLYCOLLATE in hair waving preparations except when labelled with directions for use that include the statement:
Wear protective gloves when using. Keep out of eyes.
GLYCOLIC ACID (including its salts and esters) in cosmetic products or when packed and labelled for use as an agricultural chemical except:
(a) in cosmetic preparations for salon use only, when labelled in accordance with requirements under applicable jurisdictional Work Health and Safety laws, as amended from time to time; or
(b) in preparations containing 5% or less of glycolic acid; or
(c) in preparations containing 20% or less of glycolic acid with a pH of 3.5 or greater.
GUANIDINE except:
(b) in preparations containing 1% or less of guanidine.
GUAZATINE.
HALOXON.
HALOXYFOP.
HC VIOLET 1 except:
(a) in non‑oxidative hair dye preparations containing 0.28% or less of HC Violet 1 after mixing when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use;
(b) in oxidative hair dye preparations containing 0.25% or less of HC Violet 1 after mixing under oxidative conditions when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;
HEPTACHLOR.
HEXACHLOROPHENE:
(a) in preparations for the treatment of animals; or
HEXAZINONE except when included in Schedule 5.
HEXYLOXYETHANOL except in preparations containing 10% or less of hexyloxyethanol.
HYDRAMETHYLNON except when included in Schedule 5.
HYDRAZINE.
HYDROCHLORIC ACID (excluding its salts and derivatives) except:
(b) in preparations for therapeutic use; or
(c) in preparations containing 0.5% or less of hydrochloric acid (HCl).
HYDROFLUORIC ACID (excluding its salts and derivatives) and admixtures that generate hydrofluoric acid, in preparations containing 1% or less of hydrogen fluoride except when included in Schedule 5.
HYDROGEN PEROXIDE (excluding its salts and derivatives) except:
(b) in hair dye preparations containing 6% (20 volume) or less of hydrogen peroxide; or
(c) in other preparations containing 3% (10 volume) or less of hydrogen peroxide.
HYDROQUINONE except:
(b) in preparations containing 10% or less of hydroquinone.
HYDROSILICOFLUORIC ACID (excluding its salts and derivatives) in preparations containing 1% or less of hydrosilicofluoric acid (H2SiF6) except when included in Schedule 5.
HYDROXYETHYL‑3,4‑METHYLENEDIOXYANILINE (including its salts) except in oxidative hair dye preparations containing 1.5% or less of hydroxyethyl‑3,4‑methylenedioxyaniline after mixing under oxidative conditions when the immediate container and primary pack are labelled with the following statements:
(b) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;
IMIDACLOPRID except:
(b) in preparations containing 5% or less of imidacloprid.
IMIDOCARB.
IMINOCTADINE TRIALBESILATE.
IMIPROTHRIN except:
(b) in preparations containing 10% or less of imiprothrin.
INDAZIFLAM.
INDOXACARB (includes the R and S enantiomers) except when included in Schedule 5.
INPYRFLUXAM.
IODINE (excluding its salts, derivatives and iodophors) except:
(b) in solid or semi‑solid preparations containing 2.5% or less of available iodine.
IODOPHORS except in preparations containing 1.5% or less of available iodine.
containing not more than 0.7% of free organic isocyanates boiling below 300°C.
ISOCYCLOSERAM.
ISOEUGENOL except:
(b) in preparations not intended for skin contact containing 10% or less of isoeugenol; or
(c) in preparations intended for skin contact containing 0.02% or less of isoeugenol.
ISOPYRAZAM.
ISOTIANIL.
LAMBDA‑CYHALOTHRIN:
(a) in aqueous preparations containing 25% or less of microencapsulated lambda‑cyhalothrin; or
(b) in emulsifiable granule formulations containing 25% or less lambda‑cyhalothrin; or
(c) in other preparations containing 1.6% or less of lambda‑cyhalothrin;
LASALOCID except in animal feeds containing 100 mg/kg or less of antibiotic substances.
LAURETH CARBOXYLIC ACIDS (excluding their salts and derivatives) except:
(a) in leave‑on preparations containing 1.5% or less of laureth carboxylic acids; or
(b) in wash‑off preparations containing 30% or less of laureth carboxylic acids and, if containing more than 5% of laureth carboxylic acids, when labelled with a warning to the following effect:
IF IN EYES WASH OUT IMMEDIATELY WITH WATER; or
(c) in other preparations containing 30% or less of laureth carboxylic acids and, if containing more than 5% of laureth carboxylic acids, when labelled with warnings to the following effect:
LAURYL ISOQUINOLINIUM BROMIDE.
LAURYL SULFATE SALTS (excluding their derivatives) except:
(a) in wash‑off preparations containing 30% or less of lauryl sulfates and, if containing more than 5% of lauryl sulfates, when labelled with a warning to the following effect:
IF IN EYES WASH OUT IMMEDIATELY WITH WATER; or
(b) in leave‑on preparations containing 1.5% or less of lauryl sulfates; or
(c) in toothpaste and oral hygiene preparations containing 5% or less of lauryl sulfates; or
(d) in other preparations for animal use containing 2% or less of lauryl sulfates; or
(e) in other preparations containing 30% or less of lauryl sulfates and, if containing more than 5% of lauryl sulfates, when labelled with warnings to the following effect:
LEAD COMPOUNDS except:
(b) in paints, tinters, inks or ink additives; or
(c) in preparations for cosmetic use containing 100 mg/kg or less of lead; or
(d) in pencil cores, finger colours, showcard colours, pastels, crayons, poster paints/colours or coloured chalks containing 100 mg/kg or less of lead; or
(e) in ceramic glazes when labelled with the warning statement:
CAUTION – Harmful if swallowed. Do not use on surfaces which contact food or drink;
LEPTOSPERMUM SCOPARIUM OIL (manuka oil) except:
(a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the required advisory statements for medicine labels; or
(b) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and compliant with the requirements of the required advisory statements for medicine labels; or
(c) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:
(d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and labelled with the warnings;
(e) in preparations containing 25% or less of Leptospermum scoparium oil.
LEVAMISOLE for the treatment of animals except:
(b) in preparations for the treatment of ornamental birds or ornamental fish, in packs containing 10 mg or less of levamisole.
LINDANE except when included in Schedule 2, 4 or 5.
MAFENIDE when packed and labelled for the treatment of ornamental fish only.
MALATHION except:
(b) for human therapeutic use; or
(c) in dust preparations containing 2% or less of malathion.
MCPA except when included in Schedule 5.
MCPB.
MEBENDAZOLE for the treatment of animals except when included in Schedule 5.
MECOPROP except when included in Schedule 5.
MECOPROP‑P.
MEFLUIDIDE.
MELALEUCA OIL (tea tree oil) except:
(a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the required advisory statements for medicine labels; or
(b) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and compliant with the requirements of the required advisory statements for medicine labels; or
(c) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:
(d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and labelled with the warnings:
(e) in preparations containing 25% or less of melaleuca oil.
MELENGESTROL ACETATE when used as an animal feed additive.
MELOXICAM in oral transmucosal preparations containing 1% or less meloxicam for pre‑surgical treatment and pain management in livestock during routine animal husbandry procedures.
MENAZON.
MERCAPTAMINE for cosmetic use except:
(b) in preparations containing 1% or less of mercaptamine.
MERCAPTOACETIC ACID and its salts, but excluding its derivatives, in cosmetic preparations except:
(b) in preparations containing 5% or less of mercaptoacetic acid or its salts (as mercapturic acid).
2‑MERCAPTOETHANOL in preparations for use as insect lures.
MERCURIC OXIDE for the treatment of animals, in preparations for ocular use.
MERCUROCHROME for the treatment of animals, in preparations for topical use.
METACRESOLSULPHONIC ACID AND FORMALDEHYDE CONDENSATION PRODUCT for the treatment of animals.
METALAXYL except when included in Schedule 5.
METALDEHYDE except when included in Schedule 5.
METHACRIFOS in preparations containing 60% or less of methacrifos.
METHAM.
METAMITRON.
METHANOL (excluding its derivatives) except:
(b) when included in Schedule 10; or
(c) in preparations containing 2% or less of methanol.
METHIOCARB in preparations containing 20% or less of methiocarb except when included in Schedule 5.
METHOMYL in fly‑baits containing 1% or less of methomyl and not less than 0.002% of denatonium benzoate as a bittering agent.
6‑METHOXY‑N2‑METHYL‑2,3‑PYRIDINEDIAMINE except when used in oxidative or non‑ oxidative hair dyes at a concentration of 1% or less when the immediate container and primary pack are labelled with the following statements:
(b) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye.
2‑METHOXY‑5‑NITROPHENOL.
METHYLCHLOROISOTHIAZOLINONE except:
(a) in rinse‑off cosmetic preparations or therapeutic goods intended for topical rinse‑off application containing 0.0015% or less of methylchloroisothiazolinone and methylisothiazolinone in total; or
(b) in other preparations that are not intended for direct application to the skin containing 0.1% or less of methylchloroisothiazolinone and methylisothiazolinone in total.
METHYLCYCLOPENTADIENYL MANGANESE TRICARBONYL in preparations containing 10% or less of methylcyclopentadienyl manganese tricarbonyl when fitted with a child‑resistant closure.
METHYLDIBROMO GLUTARONITRILE except when in Schedule 10.
METHYLENE BISTHIOCYANATE except in preparations containing 1% or less of methylene bisthiocyanate.
METHYLEUGENOL except in preparations containing 1% or less of methyleugenol.
METHYL ETHYL KETONE OXIME except:
(a) in viscous silicone adhesives or viscous silicone sealants containing 2.5% or less of methyl ethyl ketone oxime; or
(b) in other preparations containing 1% or less of methyl ethyl ketone oxime.
p‑METHYLAMINOPHENOL except when used in hair dye and eyebrow/eyelash colouring products at a concentration of 1% or less of p‑methylaminophenol after mixing for use when the immediate container and primary pack are labelled with the following statements:
(b) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use;
METHYL ISOTHIOCYANATE.
METHYL METHACRYLATE (excluding its derivatives) except:
(a) for cosmetic use; or
(b) in preparations containing 1% or less of methyl methacrylate as residual monomer in a polymer.
METHYL NEODECANAMIDE except in liquid preparations containing 2% or less of methyl neodecanamide.
METHYLISOTHIAZOLINONE except:
(a) in rinse‑off cosmetic preparations or therapeutic goods intended for topical rinse‑off application containing 0.0015% or less of methylisothiazolinone; or
(b) in other preparations that are not intended for direct application to the skin containing 0.1% or less of methylisothiazolinone
METHYLNORBORNYLPYRIDINE.
N‑METHYL‑2‑PYRROLIDONE except:
2‑METHYLRESORCINOL except:
(a) in non‑oxidative hair dye preparations containing 1.8% or less of 2‑methylresorcinol when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;
(b) in oxidative hair dye preparations containing 1.8% or less of 2‑methylresorcinol after mixing under oxidative conditions when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;
written in letter not less than 1.5 mm in height.
METHYLROSANILINIUM CHLORIDE (formerly known as crystal violet CAS No. 548‑62‑9) and the following TRIARYLMETHANE DYES:
except when included in Schedule 4 or Schedule 10.
METHYL SALICYLATE except:
(b) in preparations for therapeutic use; or
(c) in preparations containing 5% or less of methyl salicylate.
METOFLUTHRIN except when included in Schedule 5.
METOSULAM.
METRAFENONE except when included in Schedule 5.
METRIBUZIN.
MICONAZOLE for the external treatment of animals.
MILBEMECTIN except when included in Schedule 5.
MOMFLUOROTHRIN except in preparations containing 0.2% or less of momfluorothrin.
MONENSIN:
(a) in animal feed premixes containing 12.5% or less of antibiotic substances; or
(b) in stockfeed supplements, blocks or licks containing 0.75% or less of antibiotic substances.
MONOETHANOLAMINE (excluding its salts and derivatives) except:
(b) in preparations containing 5% or less of monoethanolamine.
MORANTEL except:
(b) in preparations containing 10% or less of morantel.
MOXIDECTIN:
(a) in preparations for external use containing 2.5% or less of moxidectin when packed in single dose tubes for the treatment of cats and dogs; or
(b) in preparations for external use containing 2% or less of moxidectin for the treatment of animals; or
(c) in preparations for internal use containing 10% or less of moxidectin for the treatment of sheep or cattle;
MSMA in herbicide or defoliant preparations containing 10% or less of MSMA.
NALED except when included in Schedule 5.
NAPHTHALENE (excluding its derivatives) except in liquid hydrocarbons.
1,5‑NAPHTHALENEDIOL except:
(a) in non‑oxidative hair dye preparations containing 1% or less of 1,5‑naphthalenediol when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;
(b) in oxidative hair dye preparations containing 1% or less of 1,5‑naphthalenediol after mixing under oxidative conditions when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;
2,7‑NAPHTHALENEDIOL except:
(a) in non‑oxidative hair dye preparations containing 1% or less of 2,7‑naphthalenediol when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;
(b) in oxidative hair dye preparations containing 1% or less of 2,7‑naphthalenediol after mixing under oxidative conditions when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;
1‑NAPHTHOL except in hair dye preparations containing 1% or less of 1‑naphthol after mixing under oxidative conditions when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;
NAPHTHALOPHOS in preparations containing 80% or less of naphthalophos.
NARASIN in animal feed premixes containing 12% or less of narasin.
NETOBIMIN for the treatment of animals except when included in Schedule 5.
NICKEL SULFATE.
NIMIDANE in preparations containing 25% or less of nimidane.
NITENPYRAM except in divided preparations containing 100 mg or less of nitenpyram.
NITRIC ACID (excluding its salts and derivatives) except:
(b) in preparations containing 0.5% or less of nitric acid (HNO3).
NITROBENZENE except:
(a) in solid or semi‑solid polishes; or
(b) in soaps containing 1% or less of nitrobenzene; or
(c) in other preparations containing 0.1% or less of nitrobenzene.
3‑NITRO‑p‑HYDROXYETHYLAMINOPHENOL except
(a) in non‑oxidative hair dye preparations containing 1.85% or less of 3‑nitro‑p‑hydroxyethylaminophenol after mixing when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;
(b) in oxidative hair dye preparations containing 3% or less of 3‑nitro‑p‑hydroxyethylaminophenol after mixing under oxidative conditions when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;
NITROPHENOLS, ortho, meta and para, except when separately specified in these Schedules.
NITROPRUSSIDES in preparations containing 2.5% or less of nitroprussides except when included in Schedule 4.
NITROUS OXIDE except when included in Schedule 4.
NITROXYNIL.
NONOXINOL 9 except:
(b) in preparations containing 25% or less of nonoxinol 9 when labelled with the statements:
(i) IRRITANT; and
(ii) Avoid contact with eyes; or
(c) in preparations containing 12.5% or less of nonoxinol 9; or
(d) in preparations for human use.
1‑OCTEN‑3‑OL except in preparations containing 5% or less of 1‑octen‑3‑ol.
OCTHILINONE except in paints, jointing compounds and sealants containing 1% or less of octhilinone calculated on the non‑volatile content.
N‑(N‑OCTYL)‑2‑PYRROLIDONE except:
OLAQUINDOX except in preparations containing 10% or less of olaquindox.
N‑OLEYL‑1,3‑DIAMINOPROPANE.
OMETHOATE in preparations containing 30% or less of omethoate except when included in Schedule 5.
OXADIAZON.
OXALIC ACID except
(a) in dental care preparations, including mouthwashes, containing 3% or less of soluble salts of oxalic acid; or
(b) its insoluble salts.
OXYCLOZANIDE.
PAECILOMYCES LILACINUS STRAIN 251.
PARAFORMALDEHYDE (excluding its derivatives) in preparations containing 0.05% or more of free formaldehyde except:
(b) in oral hygiene preparations; or
(d) in nail hardener cosmetic preparations containing 0.2% or less of free formaldehyde when labelled with the statement:
PROTECT CUTICLES WITH GREASE OR OIL; or
(e) in all other cosmetic preparations; or
(f) in other preparations containing 0.2% or less of free formaldehyde when labelled with the warning statement:
PARATHION‑METHYL in aqueous preparations containing 45% or less of microencapsulated parathion‑methyl.
PARBENDAZOLE.
PEBULATE.
PENNYROYAL OIL except:
(a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and a child‑resistant closure and compliant with the requirements of the required advisory statements for medicine labels; or
(b) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and a child‑resistant closure and labelled with the warnings:
(c) in preparations containing 4% or less of d‑pulegone.
PENTACHLOROPHENOL in preparations containing 1.5% or less of pentachlorophenol.
PERACETIC ACID except when included in Schedule 5.
PERFLUIDONE.
PERMANGANATES except potassium permanganate in aqueous solutions containing 1% or less of potassium permanganate.
PERMETHRIN except:
(b) in preparations for human therapeutic use containing 5% or less of permethrin; or
(c) in preparations containing 2% or less of permethrin.
2‑PHENOXYETHANOL except:
(a) in cosmetic preparations containing 1% or less of 2‑phenoxyethanol; or
(b) in other preparations containing 15% or less of 2‑phenoxyethanol.
PHENOL, including cresols and xylenols and any other homologue of phenol boiling below 220°C, except:
(b) in preparations containing 1% or less of phenols, and in preparations containing 3% or less of cresols and xylenols and other homologues of phenol.
PHENOTHIAZINE (excluding its derivatives) except in preparations containing 10% or less of phenothiazine.
PHENOXYMETHYL OXIRANE.
PHENYLENEDIAMINES including alkylated, arylated, halogenated and nitro derivatives not elsewhere specified in these Schedules:
(a) in preparations packed and labelled for photographic purposes; or
(b) in preparations packed and labelled for testing water except tablets containing 10 mg or less of diethyl‑para‑phenylenediamine or dimethyl‑para‑phenylenediamine in opaque strip packaging provided the directions for use include the statement, “Do not discard testing solutions into the pool”; or
(c) in hair dye preparations except when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING ‒ This product contains ingredients which may cause skin irritation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;
(d) in eyelash and eyebrow tinting products when the immediate container and primary pack are labelled with the following statement:
WARNING ‒ This product contains ingredients which may cause skin irritation to certain individuals, and when used for eyelash and eyebrow tinting may cause injury to the eye. A preliminary test according to the accompanying directions should be made before use;
PHENYL METHYL PYRAZOLONE except when used in hair dye and eyebrow/eyelash preparations at a concentration of 0.25% or less after mixing for use when the immediate container and primary pack are labelled with warning statements to the following effect:
(b) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use.
PHOSALONE.
PHOSMET.
PHOSPHORIC ACID (excluding its salts and derivatives) except:
(b) in preparations containing 15% or less of phosphoric acid (H3PO4); or
(c) in solid or semi‑solid preparations; or
(d) in professional dental kits.
PHOXIM.
o‑PHTHALALDEHYDE except when included in Schedule 5.
PICRAMIC ACID including its salts (excluding other derivatives) except when used in hair dye products at a concentration of 0.6% or less of picramic acid after mixing for use when the immediate container and primary pack are labelled with the following statements:
(b) WARNING ‒ This product contains ingredients which may cause skin allergy to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;
PINDONE.
PINE OILs when packed and labelled as a herbicide except when included in Schedule 5.
PINOXADEN except when included in Schedule 5.
PIPEROPHOS.
PIRIMICARB except when included in Schedule 5.
PIRIMIPHOS‑ETHYL.
PIRIMIPHOS‑METHYL.
POLIHEXANIDE except:
(a) in cosmetic preparations containing 0.3% or less of polihexanide; or
(b) when packed and labelled for therapeutic use; or
(c) in other preparations containing 5% or less of polihexanide.
POLIXETONIUM SALTS except:
(b) in preparations containing 1% or less of polixetonium salts.
POTASSIUM AZELOYL DIGLYCINATE except in preparations for cosmetic use containing 1% or less of potassium azeloyl diglycinate.
POTASSIUM BROMATE except in preparations containing 0.5% or less of potassium bromate.
POTASSIUM CYANATE.
POTASSIUM HYDROXIDE (excluding its salts and derivatives) except:
(a) when included in Schedule 5 or Schedule 10; or
(b) in preparations containing 5% or less of potassium hydroxide being:
(i) solid preparations, the pH of which in a 10 g/L aqueous solution is 11.5 or less; or
(ii) liquid or semi‑solid preparations, the pH of which is 11.5 or less.
POTASSIUM NITRITE in preparations containing 40% or less of potassium nitrite except:
(b) in preparations containing 0.5% or less of potassium nitrite; or
(d) in aerosols containing 2% or less of potassium nitrite.
POTASSIUM PEROXOMONOSULFATE TRIPLE SALT except:
(b) in solid orthodontic device cleaning preparations, the pH of which as an “in‑use” aqueous solution is 2.5 or more, but not more than 11.5; or
(c) in preparations containing 5% or less of potassium peroxomonosulfate triple salt being:
(i) solid preparations, the pH of which in a 10 g/L aqueous solution is 2.5 or more; or
(ii) liquid or semi‑solid preparations, the pH of which is 2.5 or more.
POTASSIUM PERSULFATE in hair preparations.
PRALLETHRIN (cis:trans=20:80) except:
(b) in insecticidal mats containing 1% or less of prallethrin.
PROCHLORAZ.
PROFENOFOS.
PROMACYL.
PROPACHLOR.
PROPARGITE.
PROPETAMPHOS.
PROPICONAZOLE except when included in Schedule 5.
PROPINEB.
PROPIONIC ACID (excluding its salts and derivatives) except:
(b) in preparations containing 30% or less of propionic acid; or
(c) for therapeutic use.
PROPOXUR except when included in Schedule 5.
n‑PROPYL ALCOHOL except:
(b) in preparations containing 5% or less of n‑propyl alcohol; or
(c) in preparations for cosmetic or therapeutic use other than in spray form.
PROQUINAZID.
PROSULFOCARB.
PROSULFURON.
PROTHIOFOS.
d‑PULEGONE except in preparations containing 4% or less of d‑pulegone.
PYRACLOFOS.
PYRAZOPHOS.
PYRIDABEN except when included in Schedule 5.
PYRIDALYL.
PYRIDATE.
PYRIPROLE.
PYRITHIONE COPPER.
PYRITHIONE ZINC except:
(b) for human use in preparations for the treatment of the scalp containing 2% or less of pyrithione zinc when compliant with the requirements of the required advisory statements for medicine labels; or
(c) in semi‑solid hair preparations for animal use; or
(d) in shampoos for animal use containing 2% or less of pyrithione zinc when labelled with the statements “Keep out of eyes” and “If in eyes rinse well with water”; or
(e) when immobilised in solid preparations containing 0.5% or less of pyrithione zinc; or
(f) in paints, jointing materials or sealants containing 0.1% or less of pyrithione zinc calculated on the non‑volatile content.
PYRIOFENONE except when included in Schedule 5.
PYROXASULFONE.
PYROXSULAM.
QUATERNARY AMMONIUM COMPOUNDS except:
(b) when included in Schedule 5; or
(c) dialkyl or dialkoyl quaternary ammonium compounds where the alkyl or alkoyl groups are derived from tallow or hydrogenated tallow or similar chain length (C16/C18) sources; or
(d) in preparations containing 5% or less of such quaternary ammonium compounds.
QUININE in cosmetic preparations except:
(a) in rinse‑off hair preparations containing 0.5% or less of quinine calculated as free base; or
(b) in leave‑on hair preparations containing 0.2% or less of quinine calculated as free base.
QUINOLINE and its salts (excluding other derivatives).
QUIZALOFOP ETHYL.
QUIZALOFOP‑p‑ETHYL except when included in Schedule 5.
QUIZALOFOP‑p‑TEFURYL.
RESCALURE for agricultural use except when enclosed in a vapour releasing device which in normal use prevents access to its contents.
RESMETHRIN except when included in Schedule 5.
RESORCINOL except:
(b) in oxidative hair dye preparations containing 1.25% or less of resorcinol after mixing for use when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;
(c) in oxidative eyelash and eyebrow dye preparations containing 1.25% or less of resorcinol after mixing for use when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use;
(d) in hair lotions/shampoo products containing 0.5% or less of resorcinol when the immediate container and primary pack are labelled with the following statement:
WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals;
ROTENONE except in solid or semi‑solid preparations containing 2% or less of rotenone.
SAFROLE except:
(b) in other preparations containing 1% or less of safrole.
SAGE OIL (Dalmatian) except:
(a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and a child‑resistant closure and compliant with the requirements of the required advisory statements for medicine labels; or
(b) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and a child‑resistant closure and labelled with the warnings:
(c) in preparations containing 4% or less of thujone.
SALINOMYCIN in animal feed premixes containing 12% or less of antibiotic substances.
SAROLANER except when included in Schedule 5.
SASSAFRAS OIL except:
(b) in other preparations containing 1% or less of safrole.
SELENIUM:
(a) in preparations containing 2.5% or less of selenium when packed and labelled:
(i) for the blueing of gun barrels; or
(ii) for photographic purposes; or
(iii) for the colouring of lead or lead alloys; or
b) in coated granules containing 1% or less of selenium for application to pasture except in fertilisers containing 200 g/tonne or less of selenium; or
(c) for the treatment of animals:
(i) in a drench, injection, paste, stocklick, vaccine or horse feed supplement containing 0.5% or less of selenium; or
(ii) in animal feed premixes containing 2% or less of selenium for the preparation of feeds containing 1 g/tonne or less of selenium; or
(iii) in controlled release bolus preparations containing 25 mg or less of selenium with a release rate not greater than 0.25 mg/day; or
(iv) as barium selenate in preparations for injection containing 5% or less of selenium.
SEMDURAMICIN in animal feed premixes for coccidiosis prevention containing 5% or less of antibiotic substances.
SILICOFLUORIDES except:
SILVER NITRATE except:
(a) when included in or expressly excluded from Schedule 2; or
(b) in preparations containing 1% or less of silver.
SINBIOALLETHRIN except:
(b) in preparations containing 1% or less of sinbioallethrin.
SODIUM ALUMINATE (excluding its salts and derivatives) except:
(a) in solid preparations, the pH of which in a 10 g/L aqueous solution is 11.5 or less; or
(b) in liquid preparations, the pH of which is 11.5 or less.
SODIUM BROMATE except in preparations containing 0.5% or less of sodium bromate.
SODIUM HYDROXIDE (excluding its salts and derivatives) except:
(a) when included in Schedule 5 or Schedule 10; or
(b) in preparations containing 5% or less of sodium hydroxide being:
(i) solid preparations, the pH of which in a 10 g/L aqueous solution is 11.5 or less; or
(ii) liquid or semi‑solid preparations, the pH of which is 11.5 or less.
SODIUM NITRITE:
(a) in preparations containing 15% or less of sodium nitrite except:
(i) when included in Schedule 2 or 5; or
(ii) in preparations containing 0.5% or less of sodium nitrite; or
(iii) when present as an excipient in preparations for therapeutic use; or
(iv) in aerosols containing 2% or less of sodium nitrite; or
(b) for use in closed‑loop water treatment systems (products).
SODIUM PERCARBONATE (CAS No. 15630‑89‑4) except:
(b) in preparations containing 15% or less of sodium percarbonate.
SODIUM PERSULFATE:
(a) in hair preparations; or
(b) in products for the treatment of water for swimming pools and spas.
SODIUM SULFIDE in preparations for use as insect lures.
SPIROPIDION.
SPIROTETRAMAT.
SPIROXAMINE.
SULCOFURON in preparations for the treatment of carpets during manufacture.
SULFAMIC ACID (excluding its salts and derivatives) except when included in Schedule 5.
SULFLURAMID.
SULFOXAFLOR except when included in Schedule 5.
SULFURIC ACID (excluding its salts and derivatives) except:
(a) in fire extinguishers; or
(b) in preparations containing 0.5% or less of sulfuric acid (H2SO4).
SULFURYL FLUORIDE.
SULPROFOS.
2,4,5‑T.
N‑TALLOW ALKYL‑1,3‑PROPANEDIAMINE DIACETATE and TALLOW ALKYLAMINE ACETATES.
TAR ACIDS distilling within the range 230‑290°C inclusive.
TCMTB (2‑[thiocyanomethylthio]benzothiazole).
TDE (1,1‑dichloro‑2,2‑bis[4‑chlorophenyl]ethane) except when included in Schedule 5.
TEBUFENPYRAD.
TEBUTHIURON.
TEMEPHOS except when in Schedule 5.
TERBUTHYLAZINE except in preparations containing 5% or less of terbuthylazine.
TERPENES, CHLORINATED.
TESTOSTERONE in implant preparations for use in animals.
TETRACHLOROETHYLENE except:
(b) in preparations containing 6% or less of tetrachloroethylene when absorbed into an inert solid; or
(c) in preparations for the treatment of animals.
TETRACONAZOLE except when included in Schedule 5.
TETRADIFON.
TETRAHYDROFURFURYL ALCOHOL (excluding its derivatives).
2,2',6,6'‑TETRAISOPROPYL‑DIPHENYL‑CARBODIIMIDE in amitraz formulations containing 2% or less of 2,2',6,6'‑tetraisopropyl‑diphenyl‑carbodiimide.
TETRAMISOLE in preparations for the treatment of animals.
THIACLOPRID.
THIAMETHOXAM except when included in Schedule 5.
THIAZAFLURON.
THIODICARB except when included in Schedule 5.
THIOMETON.
THIOPHANATE‑METHYL except when included in Schedule 5.
THIOUREA AND ALKYL THIOUREAS except:
THIRAM except in paint containing 0.5% or less of thiram.
THUJONE except in preparations containing 4% or less of thujone.
THYMOL when packed and labelled for use as a pesticide.
TIGOLANER except when in Schedule 5.
TOLUENE (excluding its derivatives) except in preparations containing 50% or less of toluene or toluene and xylene.
TOLUENEDIAMINES not elsewhere specified in these Schedules:
(a) in hair dye preparations except when the immediate container and primary pack are labelled with the following statements:
(ii) WARNING – This product contains ingredients which may cause skin irritation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;
(b) in eyelash and eyebrow tinting products when the immediate container and primary pack are labelled with the following statement:
WARNING – This product contains ingredients which may cause skin irritation to certain individuals, and when used for eyelash and eyebrow tinting may cause injury to the eye. A preliminary test according to the accompanying directions should be made before use;
(c) in nail polish preparations containing 2,5‑toluenediamine except when labelled “avoid contact with skin”.
TOLYLFLUANID.
TRANSFLUTHRIN except:
(a) in preparations containing 1% or less of transfluthrin; or
(b) in a cartridge for vaporiser use containing 600 mg or less of transfluthrin per cartridge.
TRIADIMEFON except:
(b) in fertilisers containing 5 g/kg or less of triadimefon.
TRICHLORFON except metrifonate included in Schedule 4.
TRICHLOROACETIC ACID except:
(b) in human dermal preparations containing 12.5% or less of trichloroacetic acid for the treatment of warts other than anogenital warts.
TRICHLOROETHYLENE except when included in Schedule 4.
TRICHLOROPHENOL.
TRICLABENDAZOLE except in preparations containing 20% or less of triclabendazole.
TRICLOPYR.
TRICLOSAN in cosmetic preparations for human use containing more than 0.3% of triclosan.
TRIDEMORPH.
TRIETHYL PHOSPHATE.
TRIFLUOROMETHANESULFONIC ACID.
TRINITROPHENOL (excluding its derivatives) except:
(b) in preparations containing 5% or less of trinitrophenol.
TRISODIUM NITRILOTRIACETATE except in preparations containing 20% or less of trisodium nitrilotriacetate.
VAMIDOTHION.
VINYL ACETATE MONOMER (excluding its derivatives) except:
(a) in preparations for therapeutic use; or
(b) in cosmetic preparations containing 0.01% or less of vinyl acetate as residual monomer in a polymer; or
(c) in other preparations containing 1% or less of vinyl acetate.
WARFARIN except when included in Schedule 4 or 5.
XYLENE (excluding its derivatives) except in preparations containing 50% or less of xylene or xylene and toluene.
ZERANOL in ear implants for use as a growth promotant in steer cattle.
ZETA‑CYPERMETHRIN in preparations containing 10% or less of zeta‑cypermethrin.
ZINC BORATE (excluding its derivatives) for use as an agricultural chemical.
ZINC CHLORIDE except:
(b) in preparations containing 5% or less of zinc chloride.
ZINC para‑PHENOLSULFONATE except in preparations containing 5% or less of zinc para‑phenolsulfonate.
ZINC LACTATE in toothpaste except in toothpaste preparations containing 2.5% or less of zinc lactate and labelled with the statement:
Not recommended for children under twelve years of age.
ZINC SULFATE except:
(a) when included in or expressly excluded from Schedule 4; or
(b) in other preparations containing 5% or less of zinc sulfate.